Sample Sizes for Survival Analysis Based on the Conditional Score Test for Person-time Observations
スポンサーリンク
概要
- 論文の詳細を見る
- 日本計量生物学会の論文
- 2002-09-30
著者
-
SATO Tosiya
Department of Biostatistics, Kyoto University School of Public Health
-
Sato Tosiya
Department Of Biostatistics Kyoto University School Of Public Health
-
Sato Tosiya
Department Of Epidemiology And Biostatistics Kyoto University School Of Public Health
関連論文
- Randomized controlled study on the prevention of osteoporotic fractures (OF study) : a phase IV clinical study of 15-mg menatetrenone capsules
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients : Rationale, Design, and Methods
- Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C
- Dose-response Trial of Lactoferrin in Patients with Chronic Hepatitis C
- Sample Sizes for Survival Analysis Based on the Conditional Score Test for Person-time Observations
- Assessing the Effects of Non-steroidal Anti-inflammatory Drugs on Antihypertensive Drug Therapy Using Post-Marketing Surveillance Database
- An Introduction to Epidemiologic and Statistical Methods Useful in Environmental Epidemiology
- Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients : the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex)
- Possibility of immunotherapy for biliary tract cancer : how do we prove efficacy? : Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisp
- Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma
- Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease : Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial